Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

ESP Lung Cancer Scheme Survey 2022

The European Society of Pathology Quality Assurance Organisation (ESPQA) together with QuIP GmbH is planning to introduce a ESP Lung Cancer EQA scheme with different subschemes. We therefore would like to find out how many potential participants have interest and plans to participate in any of the subschemes, as this would help us determine the maximum number of required sample sets.

 

Dear Survey Participant, 

Thank you for your time and interest in the ESP Lung Cancer EQA scheme. 

Please take 5 minutes to answer our brief survey and let us know if you're interested and planning to participate in any of our upcoming Lung Cancer EQA subschemes in 2022.  

Thank you for your support! 

 

With kind regards 

Your ESPQA Organisation and QuIP Team

There are 5 questions in this survey.
Preparatory Survey for the ESP Lung Cancer Scheme 2022
(This question is mandatory)

Please provide information about your affiliation!

In which of the following EQA subschemes would your institute or organization be interested in participating?

Multiple selection is possible. 
 

Find out more about the digital readout tests here: https://www.qualityinpathology.com/en_GB/digitalization/digital-readout-test

In which of the following EQA subschemes for mutations (molecular pathology) would your institute or organization be interested in participating? 

Multiple selection is possible.

In which of the following EQA subschemes for fusions (molecular pathology) would your institute or organization be interested in participating?

Multiple selection is possible.

Do you have any comments or suggestions?